1. Home
  2. BIAF vs LXEH Comparison

BIAF vs LXEH Comparison

Compare BIAF & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • LXEH
  • Stock Information
  • Founded
  • BIAF 2014
  • LXEH 2001
  • Country
  • BIAF United States
  • LXEH China
  • Employees
  • BIAF N/A
  • LXEH N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LXEH Other Consumer Services
  • Sector
  • BIAF Health Care
  • LXEH Real Estate
  • Exchange
  • BIAF Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • BIAF 13.0M
  • LXEH 12.5M
  • IPO Year
  • BIAF 2022
  • LXEH 2020
  • Fundamental
  • Price
  • BIAF $2.49
  • LXEH $0.50
  • Analyst Decision
  • BIAF Hold
  • LXEH
  • Analyst Count
  • BIAF 1
  • LXEH 0
  • Target Price
  • BIAF N/A
  • LXEH N/A
  • AVG Volume (30 Days)
  • BIAF 3.3M
  • LXEH 2.9M
  • Earning Date
  • BIAF 11-13-2025
  • LXEH 12-30-2025
  • Dividend Yield
  • BIAF N/A
  • LXEH N/A
  • EPS Growth
  • BIAF N/A
  • LXEH N/A
  • EPS
  • BIAF N/A
  • LXEH N/A
  • Revenue
  • BIAF $7,681,059.00
  • LXEH $4,585,942.00
  • Revenue This Year
  • BIAF N/A
  • LXEH N/A
  • Revenue Next Year
  • BIAF $20.04
  • LXEH N/A
  • P/E Ratio
  • BIAF N/A
  • LXEH N/A
  • Revenue Growth
  • BIAF 4.99
  • LXEH N/A
  • 52 Week Low
  • BIAF $2.34
  • LXEH $0.31
  • 52 Week High
  • BIAF $46.53
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 46.54
  • LXEH 29.73
  • Support Level
  • BIAF $2.43
  • LXEH $0.31
  • Resistance Level
  • BIAF $3.50
  • LXEH $0.79
  • Average True Range (ATR)
  • BIAF 0.29
  • LXEH 0.11
  • MACD
  • BIAF -0.09
  • LXEH 0.02
  • Stochastic Oscillator
  • BIAF 5.69
  • LXEH 38.45

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: